These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 8701478)

  • 1. Efficacy of oxybutynin, pseudoephedrine and indomethacin in the treatment of primary nocturnal enuresis.
    Varan B; Saatçi U; Ozen S; Bakkaloğlu A; Beşbaş N
    Turk J Pediatr; 1996; 38(2):155-9. PubMed ID: 8701478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxybutynin efficacy in the treatment of primary enuresis.
    Lovering JS; Tallett SE; McKendry JB
    Pediatrics; 1988 Jul; 82(1):104-6. PubMed ID: 3288951
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized, placebo-controlled, exploratory trial of Ibuprofen and pseudoephedrine in the treatment of primary nocturnal enuresis in children.
    Gelotte CK; Prior MJ; Gu J
    Clin Pediatr (Phila); 2009 May; 48(4):410-9. PubMed ID: 19258524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of nocturnal enuresis in children with attention deficit hyperactivity disorder.
    Chertin B; Koulikov D; Abu-Arafeh W; Mor Y; Shenfeld OZ; Farkas A
    J Urol; 2007 Oct; 178(4 Pt 2):1744-7. PubMed ID: 17707010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbamazepine to treat primary nocturnal enuresis: double-blind study.
    Al-Waili NS
    Eur J Med Res; 2000 Jan; 5(1):40-4. PubMed ID: 10657288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do holding exercises or antimuscarinics increase maximum voided volume in monosymptomatic nocturnal enuresis? A randomized controlled trial in children.
    Van Hoeck KJ; Bael A; Van Dessel E; Van Renthergem D; Bernaerts K; Vandermaelen V; Lax H; Hirche H; van Gool JD
    J Urol; 2007 Nov; 178(5):2132-6. PubMed ID: 17870123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Refractory monosymptomatic nocturnal enuresis: a combined stepwise approach in childhood and follow-up into adolescence, with attention to the clinical value of normalizing bladder capacity.
    Vermandel A; de Wachter S; Wyndaele JJ
    BJU Int; 2005 Sep; 96(4):629-33. PubMed ID: 16104923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy of imipramine with oxybutynin in children with enuresis nocturna.
    Tahmaz L; Kibar Y; Yildirim I; Ceylan S; Dayanç M
    Urol Int; 2000; 65(3):135-9. PubMed ID: 11054030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should we switch over to tolterodine in every child with non-neurogenic daytime urinary incontinence in whom oxybutynin failed?
    Yucel S; Akkaya E; Guntekin E; Kukul E; Danisman A; Akman S; Baykara M
    Urology; 2005 Feb; 65(2):369-73. PubMed ID: 15708055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of bladder capacity in antidiuretic and anticholinergic treatment for nocturnal enuresis.
    Radvanska E; Kovács L; Rittig S
    J Urol; 2006 Aug; 176(2):764-8; discussion 768-9. PubMed ID: 16813940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and urodynamic efficacy of oxybutynin and verapamil in the treatment of nocturnal enuresis after formation of orthotopic ileal neobladders. A prospective, randomized, crossover study.
    El-Bahnasawy MS; Shaaban H; Gomha MA; Nabeeh A
    Scand J Urol Nephrol; 2008; 42(4):344-51. PubMed ID: 19230167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxybutynin, desmopressin and enuresis.
    Nevéus T
    J Urol; 2001 Dec; 166(6):2459-62. PubMed ID: 11696812
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative characterization of therapeutic index: application of mixed-effects modeling to evaluate oxybutynin dose-efficacy and dose-side effect relationships.
    Gupta SK; Sathyan G; Lindemulder EA; Ho PL; Sheiner LB; Aarons L
    Clin Pharmacol Ther; 1999 Jun; 65(6):672-84. PubMed ID: 10391673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Office management of pediatric primary nocturnal enuresis: a comparison of physician advised and parent chosen alternative treatment outcomes.
    Diaz Saldano D; Chaviano AH; Maizels M; Yerkes EB; Cheng EY; Losavio J; Porten SP; Sullivan C; Zebold KF; Hagerty J; Kaplan WE
    J Urol; 2007 Oct; 178(4 Pt 2):1758-61; discussion 1762. PubMed ID: 17707433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of oxybutynin treatment on cognition in children with diurnal incontinence.
    Sommer BR; O'Hara R; Askari N; Kraemer HC; Kennedy WA
    J Urol; 2005 Jun; 173(6):2125-7. PubMed ID: 15879864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [An update on clinical and therapeutic aspects of nocturnal enuresis].
    Chiozza ML
    Pediatr Med Chir; 1997; 19(5):385-90. PubMed ID: 9493232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In which patients is the oxybutynin-desmopressin combination therapy indicated?].
    Martín-Crespo R; Luque R
    Cir Pediatr; 2003 Oct; 16(4):181-5. PubMed ID: 14677356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anticholinergic treatment in the therapy of primary enuresis. Effectiveness of oxybutynin chloride in a controlled clinical study of 58 patients].
    Marconi AM; Felici E; Roggia A; Torelli F
    Pediatr Med Chir; 1985; 7(4):573-6. PubMed ID: 3915547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient bilateral blindness and posterior reversible encephalopathy syndrome: a rare complication of enuresis treatment.
    Branson JA; Dale RC
    J Paediatr Child Health; 2008 Jun; 44(6):380-2. PubMed ID: 18476934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of oxybutynin hydrochloride in the treatment of enuresis nocturna--a clinical and urodynamic study.
    Koşar A; Arikan N; Dinçel C
    Scand J Urol Nephrol; 1999 Apr; 33(2):115-8. PubMed ID: 10360452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.